Helicobacter pylori in Gastric Mucosa-Associated Lymphoid Tissue Type Lymphoma
Infection with Helicobacter pylori triggers the acquisition of gastric mucosaassociated lymphoid tissue (MALT) and provides the background for MALT-type lymphoma development. This concept has been supported by a high association of H. pylori infection and MALT-type lymphoma and by the regression of most lymphomas after eradication therapy. In almost all patients with MALT-type lymphoma, serum antibodies to H. pylori were detectable. However, H. pylori was found only in 78% of the patients on histological examination. In addition to other effects, changes in the gastric micromilieu caused by tumor infiltration of the gastric mucosa may be responsible for the loss of the bacterium. The discrepancy of high seroprevalence and lower histological yield has been already described in other gastric diseases, e.g. atrophic gastritis or gastric carcinoma with extensive destruction of the gastric mucosa. H. pylori strains expressing the CagA protein have been associated with duodenal ulceration and gastric carcinoma. A very high percentage of patients with MALT-type lymphoma is also infected by CagA+ strains of H. pylori as tested by immunoblotting. Antibodies directed to CagA were detectable in the serum as well as in microcultured gastric mucosa. Infection with H. pylori may be a precondition for the development of gastric MALT-type lymphoma. In particular, CagA+ strains of H. pylori may, together with additional up to now unknown factors, play a role in the development of gastric MALT-type lymphoma.
KeywordsPylorus Infection Atrophic Gastritis Pylorus Strain Gastric Lymphoma CagA Protein
Unable to display preview. Download preview PDF.
- 1.Marshall BJ (1983) Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1:1273–1275Google Scholar
- 5.Foreman D, Eurogast Study Group (1993) An international association between Helicobacter pylori infection and gastric cancer. Lancet 341:359–362Google Scholar
- 7.IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (1994) Helicobacter pylori. In: Schistosomes, liver flukes, and Helicobacter pylori: views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC, Lyon, pp 177–240Google Scholar
- 26.Xiang Z, Censini S, Bayelli PF, Telford JL, Figura N, Rappuoli R, Covacci C (1995) Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major type and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun 63:94–98PubMedGoogle Scholar
- 29.Cover TL, Glupczynski Y, Lage AP, Burette A, Tummuru MKR, Perez-Perez Gl, Blaser MJ (1995) Serologic detection of infection with CagA+ Helicobacter pylori strains. J Clin Microbiol 33:496–1500Google Scholar
- 31.Covacci A, Censini S, Bugnoli M, Petracca R, Burroni D, Macchia G, Massone A, Papini E, Xiang Z, Figura N, Rappuoli R (1993) Molecular characterisation of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 90:5791–5795PubMedCrossRefGoogle Scholar
- 32.Xiang Z, Bugnoli M, Ponzetto A, Morgando A, Figura N, Covacci A, Petracca R, Pennatini C, Censini S, Armellini D, Rappuoli R (1993) Detection in an enzyme immunoassay of an immune response to a recombinant fragment of the 128 kDa protein (CagA) of Helicobacter pylori. Eur J Clin Microbiol Infect Dis 12:739–745PubMedCrossRefGoogle Scholar
- 33.Peek RM, Miller GG, Tham KT, Perez-Perez GL, Zhao X, Atherton JC, Blaser MJ (1995) Heightened inflammatory response and cytokine expression in vivo to CagA+ Helicobacter pylori strains. Lab Invest 71:760–770Google Scholar